Literature DB >> 11865282

Endocrinopathies associated with midline cerebral and cranial malformations.

Cristina Traggiai1, Richard Stanhope.   

Abstract

We systematically reviewed a series of patients (n = 85) with midline cerebral and cranial malformations to correlate the endocrinopathy with the neuroanatomic defect. Midline cleft lip and palate was associated not only with growth hormone deficiency (GHD) but also with diabetes insipidus (DI); holoprosencephaly and optic nerve hypoplasia with absence of the septum pellucidum had a similar incidence of GHD and DI. Optic nerve hypoplasia with absence of the septum pellucidum had the highest incidence of multiple pituitary endocrinopathies and of neonatal hypoglycaemia. Unilateral, although more commonly bilateral, optic nerve hypoplasia was associated with GHD.

Entities:  

Mesh:

Year:  2002        PMID: 11865282     DOI: 10.1067/mpd.2002.121822

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Brain Malformations Do Not Predict Hypopituitarism in Young Children with Optic Nerve Hypoplasia.

Authors:  Pamela Garcia-Filion; Hashem Almarzouki; Cassandra Fink; Mitchell Geffner; Marvin Nelson; Mark Borchert
Journal:  Horm Res Paediatr       Date:  2017-08-22       Impact factor: 2.852

2.  Abnormal cognitive function in treated congenital hypopituitarism.

Authors:  K Brown; J Rodgers; H Johnstone; W Adams; M Clarke; M Gibson; T Cheetham
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

3.  Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene.

Authors:  Karine Clément; Béatrice Dubern; Monica Mencarelli; Paul Czernichow; Shosuke Ito; Kazumasa Wakamatsu; Gregory S Barsh; Christian Vaisse; Juliane Leger
Journal:  J Clin Endocrinol Metab       Date:  2008-09-02       Impact factor: 5.958

Review 4.  Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly.

Authors:  Ariel F Martinez; Paul S Kruszka; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-15       Impact factor: 3.908

5.  Refining clinical phenotypes in septo-optic dysplasia based on MRI findings.

Authors:  Stefan Riedl; Jan Vosahlo; Tadej Battelino; Branka Stirn-Kranjc; Peter C Brugger; Daniela Prayer; Andrea Müllner-Eidenböck; Klaus Kapelari; Peter Blümel; Thomas Waldhör; Jan Krasny; Jan Lebl; Herwig Frisch
Journal:  Eur J Pediatr       Date:  2008-01-30       Impact factor: 3.183

6.  Incidence and associated endocrine and neurologic abnormalities of optic nerve hypoplasia.

Authors:  Brian G Mohney; Ryan C Young; Nancy Diehl
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

7.  SCREENING OF PROP-1, LHX2 AND POU1F1 MUTATIONS IN PATIENTS WITH ECTOPIC POSTERIOR PITUITARY GLAND.

Authors:  H A Korkmaz; U Karaarslan; C Eraslan; D Atila; F Hazan; V Barışık; E S Ata; O Etlik; M Yıldız; B Ozkan
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

8.  Genoa syndrome and central diabetes insipidus: a case report.

Authors:  Bülent Hacıhamdioğlu; Zeynep Şıklar; Şenay Savaş Erdeve; Merih Berberoğlu; Gülhiz Deda; Serap Teber Tıraş; Suat Fitöz; Gönül Öcal
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-05-08

9.  In-depth investigations of adolescents and adults with holoprosencephaly identify unique characteristics.

Authors:  Karin Weiss; Paul Kruszka; Maria J Guillen Sacoto; Yonit A Addissie; Donald W Hadley; Casey K Hadsall; Bethany Stokes; Ping Hu; Erich Roessler; Beth Solomon; Edythe Wiggs; Audrey Thurm; Robert B Hufnagel; Wadih M Zein; Jin S Hahn; Elaine Stashinko; Eric Levey; Debbie Baldwin; Nancy J Clegg; Mauricio R Delgado; Maximilian Muenke
Journal:  Genet Med       Date:  2017-06-22       Impact factor: 8.822

10.  Non-visualisation of cavum septi pellucidi: implication in prenatal diagnosis?

Authors:  K Hosseinzadeh; J Luo; A Borhani; L Hill
Journal:  Insights Imaging       Date:  2013-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.